Fred Hutchinson Cancer Research Center is at the forefront of a fundamental shift in how cancer is treated and cured. At Fred Hutch, PICI researcher Philip Greenberg, MD, develops new ways to empower a patient’s immune system to eradicate cancer. With PICI, he uses mouse models to characterize and test translatable strategies to treat many cancers. He also develops more effective T-cells to treat ovarian cancer through adoptive cell therapy. Tijana Martinov, PhD, a Parker Scholar in Greenberg’s lab, designs and tests T-cells that target and destroy multiple myeloma in mouse models. Philip Greenberg, MD | Investigator Tijana Martinov, PhD | Parker Scholar Related Research Focus CAR-T and Cell Therapy: The Next Wave Announcement, Press Release PICI Appoints John Connolly as Chief Scientific Officer Research Project CANDEL: A first-of-its-kind data analysis engine for scientific discovery Cancer Research Heroes, Partner Highlight A Science-Driven Partnership Announcement Our Stance on Equality Cancer Research Heroes The Power of Patient Samples Research Project REVIVE: Can we outsmart cancer by learning from the past? Announcement, Press Release PICI Appoints Frederic Pla as Chief Operating Officer Research Update Collaboration Aims to Change the Future of Cancer Care